Meeting the challenges of retention and enrollment of study participants in clinical trials during the COVID-19 pandemic from the study leadership perspective: Experience from the Zoster Eye Disease Study (ZEDS)
Open Access
- 16 November 2021
- journal article
- research article
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 24, 100875
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (NCT03134196)
- National Eye Institute (U10 EY 026869)
This publication has 4 references indexed in Scilit:
- Managing clinical trials during COVID-19: experience from a clinical research facilityTrials, 2021
- It is unprecedented: trial management during the COVID-19 pandemic and beyondTrials, 2020
- Early Impact of COVID-19 on the Conduct of Oncology Clinical Trials and Long-Term Opportunities for Transformation: Findings From an American Society of Clinical Oncology SurveyJCO Oncology Practice, 2020
- Adapting to a Pandemic — Conducting Oncology Trials during the SARS-CoV-2 PandemicClinical Cancer Research, 2020